- Home
- XNCR vs MNR Comparison
XNCR vs MNR Comparison
Compare XNCR & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | MNR |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | XNCR | MNR |
|---|---|---|
| Price | $29.82 | $10.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $41.58 | $16.86 |
| AVG Volume (30 Days) | ★ 1.5M | 429.2K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 18.55% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $125,576,000.00 | ★ $1,175,390,000.00 |
| Revenue This Year | $18.52 | $37.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.00 |
| Revenue Growth | 13.65 | ★ 21.22 |
| 52 Week Low | $10.38 | $10.15 |
| 52 Week High | $33.60 | $15.02 |
Technical Indicators
Market Signals| Indicator | XNCR | MNR |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 39.71 |
| Support Level | $22.80 | $10.49 |
| Resistance Level | $30.61 | $11.13 |
| Average True Range (ATR) | 1.71 | 0.25 |
| MACD | 0.59 | 0.03 |
| Stochastic Oscillator | 61.74 | 7.75 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas; the San Juan Basin region of New Mexico and Colorado; and the Permian Basin region of West Texas. The company is organized and managed as a single reportable segment, which is the exploration and production of oil, natural gas and NGLs (E&P Segment).